Physician profile
Salomi Salins
NPI 1609006352
$7,337.20
in general payments reported to CMS, 2019-2025
41 companies · $1,613 in 2025
The $1,613 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,967 · 2020: $293 · 2021: $206 · 2022: $374 · 2023: $801 · 2024: $1,084 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,462 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,461.96 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,142.84 | 2019 | |
| Abbvie INC. | $854.94 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Ucb, INC. | $475.70 | 2022-2025 | Fintepla, Nayzilam, Briviact |
| Supernus Pharmaceuticals, INC. | $336.52 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $286.98 | 2022-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $261.71 | 2019-2025 | |
| Allergan, INC. | $259.71 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $229.61 | 2019-2025 | |
| Livanova USA, INC. | $226.73 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ge Healthcare | $210.07 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $193.15 | 2019-2025 | Ajovy |
| Tg Therapeutics, INC. | $157.54 | 2024-2025 | |
| Imperative Care, INC | $152.40 | 2023 | Zoom 88-T Large Distal Platform |
| Abbott Laboratories | $143.36 | 2024 | Infinity |
| Merz Pharmaceuticals, LLC | $124.94 | 2024-2025 | Xeomin |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $110.59 | 2022-2025 | |
| Lundbeck LLC | $105.05 | 2021-2025 | Vyepti |
| Argenx US, INC. | $101.27 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Genzyme Corporation | $91.87 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $90.76 | 2019-2022 | |
| Octapharma USA, INC. | $89.93 | 2023 | Panzyga |
| Biogen, INC. | $62.05 | 2019-2025 | Skyclarys |
| Amneal Pharmaceuticals LLC | $60.27 | 2023-2025 | Crexont, Rytary |
| Acadia Pharmaceuticals INC | $57.64 | 2025 | Nuplazid |
| Acorda Therapeutics, INC | $49.88 | 2019 | |
| Jazz Pharmaceuticals INC. | $49.22 | 2023-2025 | |
| Lilly USA, LLC | $48.51 | 2019-2025 | Kisunla, Reyvow, Emgality |
| Sk Life Science, INC. | $48.40 | 2025 | |
| Csl Behring | $48.06 | 2025 | Hizentra, Privigen |
| Neurelis, INC. | $45.09 | 2025 | Valtoco |
| Genentech USA, INC. | $39.43 | 2024-2025 | Ocrevus Zunovo |
| Celgene Corporation | $34.16 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $28.95 | 2024 | |
| Alnylam Pharmaceuticals INC. | $25.53 | 2024 | Onpattro |
| Emd Serono, INC. | $17.93 | 2019 | |
| Avion Pharmaceuticals | $16.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.03 | 2020 | |
| Axsome Therapeutics, INC. | $14.41 | 2025 | Symbravo |
| Averitas Pharma INC. | $14.16 | 2025 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $11.21 | 2021 | |
| Sumitomo Pharma America, INC. | $4.74 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salomi Salins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.